Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing
Antiviral Research
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing. // Antiviral Research. – URL: https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing. Antiviral Research. https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all
“Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing.” Antiviral Research.
@article{article162,
title = {Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing},
journal = {Antiviral Research},
url = {https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all}
}